<DOC>
	<DOCNO>NCT01006993</DOCNO>
	<brief_summary>To assess safety feasibility use NeuroFlo catheter treat acute ischemic stroke patient follow administration intravenous tPA .</brief_summary>
	<brief_title>Feasibility Safety NeuroFlo Stroke Patients Receiving Tissue Plasminogen Activator</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Tissue Plasminogen Activator</mesh_term>
	<criteria>Ischemic stroke NIHSS 522 Persistent clinical deficit follow administration rtPA Planned thrombectomy Aortic pathology Severe heart disease Other condition doctor ass</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2010</verification_date>
</DOC>